Zevaquenabant
Zevaquenabant ((S) -MRI-1867) is a peripherally restricted, orally bioavailable dual cannabinoid CB1 receptor and inducible NOS antagonist. Zevaquenabant ameliorates obesity-induced chronic kidney disease (CKD) [1].
Product Specifications
CAS Number
[1998760-00-1]
Product Name Alternative
(S) -MRI-1867
UNSPSC
12352005
Target
Cannabinoid Receptor; NO Synthase
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/zevaquenabant.html
Purity
99.64
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=S(/N=C(N1N=C(C2=CC=C(Cl)C=C2)[C@@H](C3=CC=CC=C3)C1)/N=C(N)/C)(C4=CC=C(C(F)(F)F)C=C4)=O
Molecular Formula
C25H21ClF3N5O2S
Molecular Weight
547.98
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CB1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ZNF281 (Zinc Finger Protein 281, FLJ12859, FLJ14378, ZBP-99, ZNP-99) (MaxLight 550)
ZNF281 (Zinc Finger Protein 281, FLJ12859, FLJ14378, ZBP-99, ZNP-99) (MaxLight 550)
CD43 (T Cell Marker, Leukosialin, Sialophorin, or Leukocyte Sialoglycoprotein) (MaxLight 650)